GSK plc GSK:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:28 PM EST
36.58quote price arrow up+0.26 (+0.72%)
Volume
18,569
Close
36.32quote price arrow up+0.15 (+0.41%)
Volume
3,369,244
52 week range
28.47 - 46.97
Loading...
  • Open36.56
  • Day High36.59
  • Day Low36.23
  • Prev Close36.17
  • 52 Week High46.97
  • 52 Week High Date04/11/22
  • 52 Week Low28.47
  • 52 Week Low Date09/26/22

Key Stats

  • Market Cap74.359B
  • Shares Out2.05B
  • 10 Day Average Volume4.67M
  • Dividend1.39
  • Dividend Yield3.82%
  • Beta0.67
  • YTD % Change3.36

KEY STATS

  • Open36.56
  • Day High36.59
  • Day Low36.23
  • Prev Close36.17
  • 52 Week High46.97
  • 52 Week High Date04/11/22
  • 52 Week Low28.47
  • 52 Week Low Date09/26/22
  • Market Cap74.359B
  • Shares Out2.05B
  • 10 Day Average Volume4.67M
  • Dividend1.39
  • Dividend Yield3.82%
  • Beta0.67
  • YTD % Change3.36

RATIOS/PROFITABILITY

  • EPS (TTM)2.54
  • P/E (TTM)14.31
  • Fwd P/E (NTM)10.62
  • EBITDA (TTM)9.827B
  • ROE (TTM)34.78%
  • Revenue (TTM)35.312B
  • Gross Margin (TTM)67.98%
  • Net Margin (TTM)16.78%
  • Debt To Equity (MRQ)198.03%

EVENTS

  • Earnings Date04/26/2023
  • Ex Div Date02/23/2023
  • Div Amount0.3404
  • Split Date-
  • Split Factor-

Related Video

Pro Picks: Watch all of Monday's big stock calls on CNBC
VIDEO5:5805:58
Pro Picks: Watch all of Monday's big stock calls on CNBC

Profile

MORE
GSK plc is a global biopharma company. The Company makes vaccines and specialty medicines to prevent and treat disease. Its segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed a new monoclonal antibody treatment for COVID-19. Its product areas include vaccines, specialty medicines, and general medicines. Its vaccine portfolio...
Jonathan Symonds CBE
Independent Non-Executive Chairman of the Board
Emma Walmsley
Chief Executive Officer, Executive Director
Iain Mackay
Chief Financial Officer, Executive Director
Address